Russia: Latest MSF Updates
- Just Two Percent of People with DR-TB have Access to New, more Effective Treatments
- Russia: New TB Drugs Having Impact Against Resistance
- Training for Better Patient Care in Chechnya
- Children With TB Must Not Be Neglected
This information is excerpted from MSF’s 2016 International Activity Report.
MSF continued to run tuberculosis (TB), mental health, and cardiac care programs in Chechnya. For many years, MSF has worked closely with the Chechen Ministry of Health to implement a TB treatment program. After handing over the management of multidrug-resistant TB (MDR-TB) to the ministry, MSF focused on extensively drug-resistant TB (XDR-TB). MSF procured appropriate medicines, including new and repurposed drugs, to develop more effective treatment options. The TB program included laboratory support, health promotion, and psychosocial assistance for patients and their families.
MSF continued to care for XDR-TB patients with diabetes co-morbidity. A total of 60 patients with diabetes and TB and 79 patients with XDR-TB were under treatment in December 2016. Teams in the mental health program provided individual psychosocial care for 4,838 patients and 314 group counseling sessions for victims of violence.
MSF continued to support cardiac care in the emergency hospital in the Chechen capital, Grozny, and in Urus-Martan Hospital by supplying drugs and medical equipment and improving the quality of care for acute patients. A master class was organized with specialists from the Medical University of Dusseldorf to enhance the technical skills of the Grozny interventional cardiology team. In 2016, the cardiac resuscitation unit admitted 1,327 acute patients, 413 of whom benefited from an angiography, and 397 from an angioplasty.